COVID-19 and Meningococcal Vaccination Guidelines

Introduction to Vaccination Timing

COVID-19 vaccines and meningococcal vaccines can be administered simultaneously or at any interval without waiting between doses, as recommended by the Advisory Committee on Immunization Practices (ACIP) 1
Inactivated vaccines like meningococcal vaccines (MenACWY) can be administered either simultaneously or at any time before or after COVID-19 vaccines without requiring a waiting period, according to the Centers for Disease Control and Prevention (CDC) 1
Simultaneous administration of all indicated vaccines increases the likelihood of complete vaccination and provides timely protection against preventable diseases, as stated by the American Academy of Pediatrics (AAP) 1
The immune response to inactivated vaccines is not affected by other vaccines, allowing for concurrent administration, as supported by the National Institute of Allergy and Infectious Diseases (NIAID) 1

For persons aged ≥6 months, the Advisory Committee on Immunization Practices (ACIP) recommends vaccination with 2024-2025 COVID-19 vaccines as authorized or approved, with a strength of evidence rated as high 2
Depending on previous vaccination history and immune status, different dosing schedules apply, including 1 dose of Moderna or Pfizer-BioNTech, or 2 doses of Novavax (for those ≥12 years), as recommended by the CDC 2
Those who previously received ≥1 COVID-19 vaccine dose need 1 additional dose of any 2024-2025 COVID-19 vaccine, administered ≥8 weeks after the last dose, according to the ACIP 2

Meningococcal vaccines are recommended based on age and risk factors, with a strength of evidence rated as moderate to high, as stated by the CDC 3, 4, 5
For healthy adolescents, MenACWY is recommended at age 11-12 years with a booster dose at age 16 years, as recommended by the American Academy of Pediatrics (AAP) 6
For persons at increased risk (e.g., with complement deficiencies, asplenia, HIV), specific schedules apply, including a 2-dose primary series administered 8 weeks apart, as recommended by the CDC 3

Document all vaccines administered in the patient's permanent medical record, as recommended by the American Medical Association (AMA) 1
Do not mix individual vaccines in the same syringe unless specifically approved for mixing by the FDA, as stated by the CDC 1
For persons with certain medical conditions (e.g., asplenia, complement deficiencies), additional doses and specific timing may be required for both COVID-19 and meningococcal vaccines, as recommended by the ACIP and CDC 2, 3
For immunocompromised patients, more doses of COVID-19 vaccine may be recommended (e.g., 3-dose primary series for unvaccinated persons aged 6 months-11 years), as stated by the CDC 2